Trial Profile

A Phase 3, Multi-Center, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of CK-3773274 in Adults With Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 11 May 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

28 Apr 2026 According to a Cytokinetics media release, data from this trial will be presented at the European Society of Cardiology Heart Failure 2026 Congress taking place in Barcelona, Spain, from May 9-12, 2026.
16 Mar 2026 Results presented in the Cytokinetics Media Release.
16 Mar 2026 According to a Cytokinetics media release, data from analysis of this study will be presented in a Poster Presentation, March 29, 2026, 2PM-3PM CT at the American College of Cardiology (ACC) Annual Scientific Session & Expo taking place March 28-30, 2026 in New Orleans, LA.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com